Breaking News Instant updates and real-time market news.

JBAXY

Julius Baer

$0.00 /

+ (+0.00%)

06:27
04/09/20
04/09
06:27
04/09/20
06:27

Julius Baer price target lowered to EUR 49.50 from EUR 58.50 at Credit Suisse

Credit Suisse analyst Jon Peace lowered the firm's price target on Julius Baer to EUR 49.50 from EUR 58.50 and keeps an Outperform rating on the shares to reflect the COVID-19 pandemic. In a research note to investors, Peace says he sees the balance sheet light model as a relative advantage heading into a severe credit cycle. He sees Swiss banks as a relatively safe haven amid the pandemic.

JBAXY Julius Baer
$0.00 /

+ (+0.00%)

03/12/20 UBS
Julius Baer price target lowered to CHF 35 from CHF 50 at UBS
02/10/20 Morgan Stanley
Julius Baer upgraded to Overweight from Equal Weight at Morgan Stanley
01/15/20 Jefferies
Julius Baer initiated with a Buy at Jefferies
10/21/19 Citi
Julius Baer downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

On The Fly
Moderna rises, Novavax plunges as White House names COVID finalists » 14:17
06/03/20
06/03
14:17
06/03/20
14:17
MRNA

Moderna

$60.70 /

+0.82 (+1.37%)

, INO

Inovio

$12.48 /

-1.89 (-13.15%)

, NVAX

Novavax

$42.29 /

-7.28 (-14.69%)

, AZN

AstraZeneca

$55.25 /

+0.535 (+0.98%)

, JNJ

Johnson & Johnson

$148.00 /

-0.16 (-0.11%)

, MRK

Merck

$82.13 /

+1.28 (+1.58%)

, PFE

Pfizer

$35.97 /

-0.19 (-0.53%)

Shares of Moderna (MRNA)…

Open Full Text

ShowHide Related Items >><<
MRNA Moderna
$60.70 /

+0.82 (+1.37%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
INO Inovio
$12.48 /

-1.89 (-13.15%)

06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
05/20/20 Piper Sandler
Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
NVAX Novavax
$42.29 /

-7.28 (-14.69%)

05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.13 /

+1.28 (+1.58%)

11:41 Today Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
MRNA Moderna
$60.70 /

+0.82 (+1.37%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

Technical Analysis
NASDAQ market internals summary » 14:17
06/03/20
06/03
14:17
06/03/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 14:16
06/03/20
06/03
14:16
06/03/20
14:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Glu Mobile, Zynga fall after Reuters report on gaming company Playtika's US IPO » 14:13
06/03/20
06/03
14:13
06/03/20
14:13
GLUU

Glu Mobile

$9.38 /

-0.57 (-5.73%)

, ZNGA

Zynga

$9.28 /

-0.3 (-3.13%)

Shares of Glu Mobile…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLUU Glu Mobile
$9.38 /

-0.57 (-5.73%)

ZNGA Zynga
$9.28 /

-0.3 (-3.13%)

GLUU Glu Mobile
$9.38 /

-0.57 (-5.73%)

05/29/20 Benchmark
Benchmark reiterates Buy rating on Glu Mobile after guidance hike
05/29/20 Piper Sandler
Glu Mobile outlook still conservative despite uptick, says Piper Sandler
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 Morgan Stanley
Morgan Stanley downgrades Glu Mobile after stock nearly doubled
ZNGA Zynga
$9.28 /

-0.3 (-3.13%)

06/02/20 Jefferies
Zynga price target raised to $11 from $9 at Jefferies
06/02/20 Barclays
Zynga price target raised to $9.50 from $7.50 at Barclays
06/02/20 Benchmark
Zynga price target raised to $11 from $9 at Benchmark
06/02/20 Piper Sandler
Zynga price target raised to $11 from $8.50 at Piper Sandler
GLUU Glu Mobile
$9.38 /

-0.57 (-5.73%)

ZNGA Zynga
$9.28 /

-0.3 (-3.13%)

  • 04
    Jun
ZNGA Zynga
$9.28 /

-0.3 (-3.13%)

GLUU Glu Mobile
$9.38 /

-0.57 (-5.73%)

ZNGA Zynga
$9.28 /

-0.3 (-3.13%)

GLUU Glu Mobile
$9.38 /

-0.57 (-5.73%)

ZNGA Zynga
$9.28 /

-0.3 (-3.13%)

Options
Cognizant call volume above normal and directionally bullish » 14:05
06/03/20
06/03
14:05
06/03/20
14:05
CTSH

Cognizant

$54.83 /

+1.58 (+2.97%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$54.83 /

+1.58 (+2.97%)

CTSH Cognizant
$54.83 /

+1.58 (+2.97%)

05/08/20 Bernstein
Cognizant downgraded to Market Perform from Outperform at Bernstein
05/04/20
Fly Intel: Top five analyst downgrades
05/04/20 BMO Capital
Cognizant downgraded to Market Perform from Outperform at BMO Capital
04/14/20 Wells Fargo
Cognizant price target lowered to $60 from $76 at Wells Fargo
CTSH Cognizant
$54.83 /

+1.58 (+2.97%)

CTSH Cognizant
$54.83 /

+1.58 (+2.97%)

CTSH Cognizant
$54.83 /

+1.58 (+2.97%)

CTSH Cognizant
$54.83 /

+1.58 (+2.97%)

Periodicals
Manulife CEO sees continued lower rates as a challenge, Reuters says » 14:02
06/03/20
06/03
14:02
06/03/20
14:02
MFC

Manulife Financial

$13.66 /

+0.55 (+4.20%)

Manulife Financial CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MFC Manulife Financial
$13.66 /

+0.55 (+4.20%)

MFC Manulife Financial
$13.66 /

+0.55 (+4.20%)

05/15/20 Credit Suisse
Manulife Financial upgraded to Outperform from Neutral at Credit Suisse
05/08/20 Canaccord
Manulife Financial price target lowered to C$22 from C$24 at Canaccord
05/08/20 Scotiabank
Manulife Financial price target lowered to C$21 from C$22 at Scotiabank
05/07/20 National Bank
Manulife downgraded to Sector Perform from Outperform at National Bank
MFC Manulife Financial
$13.66 /

+0.55 (+4.20%)

MFC Manulife Financial
$13.66 /

+0.55 (+4.20%)

Periodicals
HSBC, StanChart support China security law for Hong Kong, Reuters says » 14:00
06/03/20
06/03
14:00
06/03/20
14:00
HSBC

HSBC

$25.28 /

+1.125 (+4.66%)

, SCBFF

Standard Chartered

$0.00 /

+ (+0.00%)

HSBC (HSBC) and Standard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$25.28 /

+1.125 (+4.66%)

SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

HSBC HSBC
$25.28 /

+1.125 (+4.66%)

05/31/20 Jefferies
Standard Chartered upgraded to Buy from Underperform at Jefferies
05/31/20 Jefferies
HSBC downgraded to Hold from Buy at Jefferies
05/14/20 Berenberg
HSBC upgraded to Hold from Sell at Berenberg
05/12/20 RBC Capital
HSBC price target lowered to 410 GBp from 440 GBp at RBC Capital
SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

05/31/20 Jefferies
Standard Chartered upgraded to Buy from Underperform at Jefferies
05/21/20 Exane BNP Paribas
Standard Chartered upgraded to Neutral from Underperform at Exane BNP Paribas
03/17/20 HSBC
Standard Chartered upgraded to Hold from Reduce at HSBC
03/16/20 Citi
Standard Chartered upgraded to Buy from Neutral at Citi
HSBC HSBC
$25.28 /

+1.125 (+4.66%)

HSBC HSBC
$25.28 /

+1.125 (+4.66%)

SCBFF Standard Chartered
$0.00 /

+ (+0.00%)

HSBC HSBC
$25.28 /

+1.125 (+4.66%)

HSBC HSBC
$25.28 /

+1.125 (+4.66%)

Downgrade
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers » 13:57
06/03/20
06/03
13:57
06/03/20
13:57
PPC

Pilgrim's Pride

$18.34 /

-2.54 (-12.16%)

, TSN

Tyson Foods

$59.72 /

-2.78 (-4.45%)

, SAFM

Sanderson Farms

$123.58 /

-6.9299 (-5.31%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPC Pilgrim's Pride
$18.34 /

-2.54 (-12.16%)

TSN Tyson Foods
$59.72 /

-2.78 (-4.45%)

SAFM Sanderson Farms
$123.58 /

-6.9299 (-5.31%)

PPC Pilgrim's Pride
$18.34 /

-2.54 (-12.16%)

13:44 Today Stephens
Pilgrim's Pride downgraded to Equal Weight from Overweight at Stephens
05/11/20 Stephens
Stephens upgrades Pilgrim's Pride, says navigating current environment well
05/11/20 Stephens
Pilgrim's Pride upgraded to Overweight from Equal Weight at Stephens
03/31/20 Barclays
Beyond Meat price target lowered to $100 from $130 at Barclays
TSN Tyson Foods
$59.72 /

-2.78 (-4.45%)

05/28/20
Fly Intel: Top five analyst downgrades
05/28/20 Argus
Tyson Foods downgraded to Hold from Buy at Argus
05/28/20 Argus
Tyson Foods downgraded to Hold from Buy at Argus
05/05/20
Fly Intel: Top five analyst downgrades
SAFM Sanderson Farms
$123.58 /

-6.9299 (-5.31%)

05/11/20 Stephens
Sanderson Farms price target raised to $150 from $110 at Stephens
04/03/20 Credit Suisse
Sanderson Farms price target lowered to $135 from $160 at Credit Suisse
04/02/20
Fly Intel: Top five analyst downgrades
04/02/20 BofA
Sanderson Farms downgraded to Neutral from Buy at BofA
PPC Pilgrim's Pride
$18.34 /

-2.54 (-12.16%)

TSN Tyson Foods
$59.72 /

-2.78 (-4.45%)

SAFM Sanderson Farms
$123.58 /

-6.9299 (-5.31%)

PPC Pilgrim's Pride
$18.34 /

-2.54 (-12.16%)

TSN Tyson Foods
$59.72 /

-2.78 (-4.45%)

SAFM Sanderson Farms
$123.58 /

-6.9299 (-5.31%)

PPC Pilgrim's Pride
$18.34 /

-2.54 (-12.16%)

TSN Tyson Foods
$59.72 /

-2.78 (-4.45%)

SAFM Sanderson Farms
$123.58 /

-6.9299 (-5.31%)

TSN Tyson Foods
$59.72 /

-2.78 (-4.45%)

Hot Stocks
Advertising tech stocks spike higher after Criteo says revenue trends better » 13:54
06/03/20
06/03
13:54
06/03/20
13:54
CRTO

Criteo

$13.00 /

+1.82 (+16.28%)

, RUBI

Rubicon Project

$7.66 /

+1.07 (+16.24%)

, CDLX

Cardlytics

$76.92 /

+2.8 (+3.78%)

, QNST

QuinStreet

$11.23 /

+0.38 (+3.50%)

, TTD

Trade Desk

$344.74 /

+26.71 (+8.40%)

, TTGT

TechTarget

$28.13 /

+0.78 (+2.85%)

Shares of companies who…

Shares of companies who have businesses relate to the advertising technology space are higher after one of their peers, Criteo (CRTO), made encouraging statements on Wednesday. CRITEO COMMENTARY: The advertising tech company on Wednesday provided an interim update on its second quarter financial performance, saying that "a continued decline of the company's revenues for the month of May compared to April had not materialized as anticipated." As of May 29, Criteo said overall revenue trends have been better than were expected at the time of the company's April 29 guidance for the second quarter of 2020. Additionally, the company believes it is on track to achieve its cost savings targets as anticipated in its April 29 guidance for the second quarter. ANALYST HAD LOWERED TARGETS: In early May, both Deutsche Bank and SunTrust lowered their price targets on Criteo. Deutsche Bank analyst Lloyd Walmsley lowered the firm's price target on Criteo to $16 from $22 on May 8 and kept a Buy rating on the shares. SunTrust analyst Matthew Thornton lowered the firm's price target on Criteo to $13 from $25 and also kept a Buy rating on the shares. Thornton said in a research note at the time that he sees Q1 results as "solid" given the COVID-19 outbreak and the FX headwinds, while adjusting his model to 10-times expected free cash flows and for enterprise value at 0.2-times expected gross sales. Thornton remained positive on Criteo's "very reasonable consensus and expected continued cash generation." PRICE ACTION: Shares of Criteo are up nearly 17% to $13.00 in afternoon trading. PEERS TRADE HIGHER: Advertising technology peers are higher, including Rubicon Project (RUBI), Cardlytics (CDLX), QuinStreet (QNST), Trade Desk (TTD) and TechTarget (TTGT).

ShowHide Related Items >><<
CRTO Criteo
$13.00 /

+1.82 (+16.28%)

RUBI Rubicon Project
$7.66 /

+1.07 (+16.24%)

CDLX Cardlytics
$76.92 /

+2.8 (+3.78%)

QNST QuinStreet
$11.23 /

+0.38 (+3.50%)

TTD Trade Desk
$344.74 /

+26.71 (+8.40%)

TTGT TechTarget
$28.13 /

+0.78 (+2.85%)

CRTO Criteo
$13.00 /

+1.82 (+16.28%)

05/08/20 Deutsche Bank
Criteo price target lowered to $16 from $22 at Deutsche Bank
05/05/20 SunTrust
Criteo price target lowered to $13 from $25 at SunTrust
04/20/20 Nomura Instinet
Criteo price target lowered to $10 from $14 at Nomura Instinet
04/08/20 Societe Generale
Criteo upgraded to Buy from Hold at Societe Generale
RUBI Rubicon Project
$7.66 /

+1.07 (+16.24%)

04/02/20 Craig-Hallum
Rubicon Project price target lowered to $9 from $14 at Craig-Hallum
01/15/20 Stephens
Google cookie announcement widely anticipated, concerns overblown, says Stephens
01/14/20 SunTrust
SunTrust sees little disruption to Rubicon following Google cookie news
01/09/20 Craig-Hallum
Rubicon Project, Telaria shares can continue to move higher, says Craig-Hallum
CDLX Cardlytics
$76.92 /

+2.8 (+3.78%)

05/12/20 Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
05/12/20 SunTrust
Cardlytics price target raised to $55 from $50 at SunTrust
05/12/20 Wells Fargo
Cardlytics price target raised to $55 from $45 at Wells Fargo
04/21/20 BofA
Cardlytics downgraded to Underperform from Neutral at BofA
QNST QuinStreet
$11.23 /

+0.38 (+3.50%)

05/07/20 Lake Street
QuinStreet price target lowered to $11 from $19 at Lake Street
04/16/20 Barrington
QuinStreet downgraded to Market Perform from Outperform at Barrington
08/15/19 Barrington
QuinStreet price target lowered to $16 from $20 at Barrington
08/09/19 Stephens
Stephens recommends buying QuinStreet on weakness
TTD Trade Desk
$344.74 /

+26.71 (+8.40%)

05/14/20 Rosenblatt
Trade Desk price target raised to $215 from $171 at Rosenblatt
05/11/20 DA Davidson
Trade Desk downgraded to Neutral from Buy at DA Davidson
05/11/20 DA Davidson
Trade Desk downgraded to Neutral from Buy at DA Davidson
05/08/20 Needham
Trade Desk price target raised to $370 from $250 at Needham
TTGT TechTarget
$28.13 /

+0.78 (+2.85%)

04/13/20
Fly Intel: Top five analyst initiations
04/13/20 National Securities
TechTarget initiated with a Buy at National Securities
11/07/19 Lake Street
TechTarget price target raised to $29 from $24 at Lake Street
CRTO Criteo
$13.00 /

+1.82 (+16.28%)

RUBI Rubicon Project
$7.66 /

+1.07 (+16.24%)

CDLX Cardlytics
$76.92 /

+2.8 (+3.78%)

QNST QuinStreet
$11.23 /

+0.38 (+3.50%)

TTD Trade Desk
$344.74 /

+26.71 (+8.40%)

TTGT TechTarget
$28.13 /

+0.78 (+2.85%)

CRTO Criteo
$13.00 /

+1.82 (+16.28%)

RUBI Rubicon Project
$7.66 /

+1.07 (+16.24%)

CDLX Cardlytics
$76.92 /

+2.8 (+3.78%)

TTD Trade Desk
$344.74 /

+26.71 (+8.40%)

TTGT TechTarget
$28.13 /

+0.78 (+2.85%)

CDLX Cardlytics
$76.92 /

+2.8 (+3.78%)

TTD Trade Desk
$344.74 /

+26.71 (+8.40%)

Downgrade
Pilgrim's Pride downgraded to Equal Weight from Overweight at Stephens » 13:44
06/03/20
06/03
13:44
06/03/20
13:44
PPC

Pilgrim's Pride

$18.60 /

-2.28 (-10.92%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPC Pilgrim's Pride
$18.60 /

-2.28 (-10.92%)

PPC Pilgrim's Pride
$18.60 /

-2.28 (-10.92%)

05/11/20 Stephens
Stephens upgrades Pilgrim's Pride, says navigating current environment well
05/11/20 Stephens
Pilgrim's Pride upgraded to Overweight from Equal Weight at Stephens
03/31/20 Barclays
Beyond Meat price target lowered to $100 from $130 at Barclays
02/24/20 Goldman Sachs
Pilgrim's Pride price target lowered to $27 from $30 at Goldman Sachs
PPC Pilgrim's Pride
$18.60 /

-2.28 (-10.92%)

PPC Pilgrim's Pride
$18.60 /

-2.28 (-10.92%)

PPC Pilgrim's Pride
$18.60 /

-2.28 (-10.92%)

On The Fly
Roku slides after partner launches new Android-powered smart TVs » 13:43
06/03/20
06/03
13:43
06/03/20
13:43
ROKU

Roku

$105.95 /

-4.875 (-4.40%)

Shares of Roku (ROKU) are…

Open Full Text

ShowHide Related Items >><<
ROKU Roku
$105.95 /

-4.875 (-4.40%)

ROKU Roku
$105.95 /

-4.875 (-4.40%)

12:10 Today Stephens
Roku may be seeing pressure from Best Buy TCL TVs, says Stephens
11:53 Today SunTrust
New TVs at Best Buy present 'modest' new competition for Roku, says Suntrust
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Stephens
Roku downgraded to Equal Weight on worries about TCL at Stephens
ROKU Roku
$105.95 /

-4.875 (-4.40%)

ROKU Roku
$105.95 /

-4.875 (-4.40%)

ROKU Roku
$105.95 /

-4.875 (-4.40%)

ROKU Roku
$105.95 /

-4.875 (-4.40%)

Options
Size put spread in financial sector ETF on Amex rolls hedge » 13:40
06/03/20
06/03
13:40
06/03/20
13:40
XLF

Financial Select Sector

$24.75 /

+0.89 (+3.73%)

Size put spread in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLF Financial Select Sector
$24.75 /

+0.89 (+3.73%)

XLF Financial Select Sector
$24.75 /

+0.89 (+3.73%)

XLF Financial Select Sector
$24.75 /

+0.89 (+3.73%)

Syndicate
Allena Pharmaceuticals announces $15M registered direct offering » 13:27
06/03/20
06/03
13:27
06/03/20
13:27
ALNA

Allena Pharmaceuticals

$2.77 /

+0.07 (+2.59%)

Allena Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
$2.77 /

+0.07 (+2.59%)

ALNA Allena Pharmaceuticals
$2.77 /

+0.07 (+2.59%)

06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
02/12/20 Roth Capital
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
12/06/19 Wedbush
Allena Pharmaceuticals selloff 'overdone,' says Wedbush
ALNA Allena Pharmaceuticals
$2.77 /

+0.07 (+2.59%)

Recommendations
Tullow Oil price target lowered to 24 GBp from 61 GBp at Morgan Stanley » 13:25
06/03/20
06/03
13:25
06/03/20
13:25
TUWOY

Tullow Oil

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TUWOY Tullow Oil
$0.00 /

+ (+0.00%)

04/29/20 Berenberg
Tullow Oil price target lowered to 55 GBp from 80 GBp at Berenberg
04/28/20 Jefferies
Tullow Oil price target raised to 12 GBp from 5 GBp at Jefferies
04/27/20 Renaissance Capital
Tullow Oil upgraded to Hold from Sell at Renaissance Capital
04/01/20 Barclays
Tullow Oil downgraded to Underweight from Equal Weight at Barclays
TUWOY Tullow Oil
$0.00 /

+ (+0.00%)

Options
Bausch Health call volume above normal and directionally bullish » 13:25
06/03/20
06/03
13:25
06/03/20
13:25
BHC

Bausch Health

$19.03 /

+0.12 (+0.63%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$19.03 /

+0.12 (+0.63%)

BHC Bausch Health
$19.03 /

+0.12 (+0.63%)

08:30 Today Jefferies
Duobrii could become a key revenue driver for Bausch Health, says Jefferies
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Bausch Health initiated with a Buy at Citi
04/02/20 Morgan Stanley
Bausch Health downgraded to Equal Weight with $17 price target at Morgan Stanley
BHC Bausch Health
$19.03 /

+0.12 (+0.63%)

BHC Bausch Health
$19.03 /

+0.12 (+0.63%)

BHC Bausch Health
$19.03 /

+0.12 (+0.63%)

Conference/Events
Ryman Hospitality participates in a conference call with JPMorgan » 13:25
06/03/20
06/03
13:25
06/03/20
13:25
RHP

Ryman Hospitality

$40.24 /

+3.04 (+8.17%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHP Ryman Hospitality
$40.24 /

+3.04 (+8.17%)

RHP Ryman Hospitality
$40.24 /

+3.04 (+8.17%)

05/11/20 Deutsche Bank
Deutsche keeps Buy on Ryman despite 'shiny new' videoconferencing 'toys'
04/07/20 Wells Fargo
Ryman Hospitality price target lowered to $44 from $68 at Wells Fargo
04/07/20 Citi
Ryman Hospitality downgraded to Neutral from Buy at Citi
04/03/20 Raymond James
Ryman Hospitality price target lowered to $45 from $65 at Raymond James
RHP Ryman Hospitality
$40.24 /

+3.04 (+8.17%)

Recommendations
Lundin Energy price target lowered to SEK 245 from SEK 325 at Morgan Stanley » 13:24
06/03/20
06/03
13:24
06/03/20
13:24
LNDNF

Lundin Energy

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LNDNF Lundin Energy
$0.00 /

+ (+0.00%)

05/27/20 DNB Markets
Lundin Energy initiated with a Hold at DNB Markets
05/22/20 JPMorgan
Lundin Energy price target raised to SEK 265 from SEK 256 at JPMorgan
05/12/20 Credit Suisse
Lundin Energy initiated with an Underperform at Credit Suisse
05/12/20 Credit Suisse
Aker BP initiated with a Neutral at Credit Suisse
Hot Stocks
Moderna jumps 4% to $62.24 after making White House vaccine finalist list  13:21
06/03/20
06/03
13:21
06/03/20
13:21
MRNA

Moderna

$60.25 /

+0.37 (+0.62%)

 
ShowHide Related Items >><<
MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

MRNA Moderna
$60.25 /

+0.37 (+0.62%)

Recommendations
Aker BP price target lowered to NOK 205 from NOK 320 at Morgan Stanley » 13:21
06/03/20
06/03
13:21
06/03/20
13:21
DETNF

Aker BP

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DETNF Aker BP
$0.00 /

+ (+0.00%)

05/12/20 Credit Suisse
Aker BP initiated with a Neutral at Credit Suisse
05/12/20 Credit Suisse
Aker BP initiated with a Neutral at Credit Suisse
05/07/20 Barclays
Aker BP price target raised to NOK 245 from NOK 230 at Barclays
05/07/20 Berenberg
Aker BP upgraded to Buy from Hold at Berenberg
Hot Stocks
Inovio drops 7% to $13.32 after White House omits as vaccine finalist  13:18
06/03/20
06/03
13:18
06/03/20
13:18
INO

Inovio

$13.86 /

-0.51 (-3.55%)

 
ShowHide Related Items >><<
INO Inovio
$13.86 /

-0.51 (-3.55%)

INO Inovio
$13.86 /

-0.51 (-3.55%)

06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
05/20/20 Piper Sandler
Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
INO Inovio
$13.86 /

-0.51 (-3.55%)

INO Inovio
$13.86 /

-0.51 (-3.55%)

INO Inovio
$13.86 /

-0.51 (-3.55%)

INO Inovio
$13.86 /

-0.51 (-3.55%)

Hot Stocks
General Motors encouraged by return of auto sales  13:17
06/03/20
06/03
13:17
06/03/20
13:17
GM

General Motors

$28.72 /

+1.3 (+4.74%)

 
ShowHide Related Items >><<
GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

05/19/20 Argus
General Motors EPS view cut at Argus
05/11/20 Nomura Instinet
General Motors price target lowered to $23 from $36 at Nomura Instinet
05/08/20 Jefferies
Jefferies prefers Ford although GM resilience put it 'to shame' in Q1
05/07/20
Fly Intel: Top five analyst upgrades
GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

Hot Stocks
General Motors CEO sees close to normal capacity in Mexico in June » 13:17
06/03/20
06/03
13:17
06/03/20
13:17
GM

General Motors

$28.72 /

+1.3 (+4.74%)

Comments taken from Wolfe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

05/19/20 Argus
General Motors EPS view cut at Argus
05/11/20 Nomura Instinet
General Motors price target lowered to $23 from $36 at Nomura Instinet
05/08/20 Jefferies
Jefferies prefers Ford although GM resilience put it 'to shame' in Q1
05/07/20
Fly Intel: Top five analyst upgrades
GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

GM General Motors
$28.72 /

+1.3 (+4.74%)

Technical Analysis
NASDAQ market internals summary » 13:17
06/03/20
06/03
13:17
06/03/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Periodicals
Novavax sinks after White House omits as COVID vaccine finalist » 13:16
06/03/20
06/03
13:16
06/03/20
13:16
MRK

Merck

$81.74 /

+0.89 (+1.10%)

, AZN

AstraZeneca

$54.71 /

-0.005 (-0.01%)

, PFE

Pfizer

$35.72 /

-0.44 (-1.22%)

, JNJ

Johnson & Johnson

$147.44 /

-0.72 (-0.49%)

, MRNA

Moderna

$59.63 /

-0.25 (-0.42%)

, NVAX

Novavax

$48.10 /

-1.47 (-2.97%)

The New York Times this…

The New York Times this afternoon reported that Moderna (MRNA) is among the five finalists selected by the Trump administration as the most likely to produce a vaccine for the coronavirus. By narrowing the field, the White House is betting it can identify the most promising vaccines at an early stage, speed along the process of determining which will work and ensure that the winner or winners can be quickly manufactured in large quanities, the Times said. A White House announcement is expected in the new few weeks. In addition to Moderna, the winners are AstraZeneca (AZN), Johnson & Johnson (JNJ), Merck (MRK) and Pfizer (PFE), according the Times. Shares of Moderna are down 11c to $59.76 in afternoon trading. Novavax (NVAX) shares are down 14% to $42.60 after not being selected as a finalist.

ShowHide Related Items >><<
MRK Merck
$81.74 /

+0.89 (+1.10%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

11:41 Today Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRNA Moderna
$59.63 /

-0.25 (-0.42%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
NVAX Novavax
$48.10 /

-1.47 (-2.97%)

05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
MRK Merck
$81.74 /

+0.89 (+1.10%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

Technical Analysis
NYSE market internals summary » 13:16
06/03/20
06/03
13:16
06/03/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.